CZ

Czech Republic

6936 clinical trials

Find Trials

Clinical Trials (6936)

Showing 20 of 6,936 trialsScroll for more
NCT06159673Phase 28 sites

ACP-204 in Adults With Alzheimer's Disease Psychosis

Recruiting
NCT06966700Phase 34 sites

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Recruiting
NCT07091630Phase 31 site

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Recruiting
NCT04728893Phase 22 sites

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Recruiting
NCT06290128Phase 33 sites

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

Recruiting
NCT07181109Phase 320 sites

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Recruiting
NCT06467357Phase 36 sites

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Recruiting
NCT06637631Phase 24 sites

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Recruiting
NCT07226765Phase 33 sites

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Recruiting
NCT07216703Phase 35 sites

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Recruiting
NCT06072482Phase 47 sites

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Recruiting

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

Enrolling By Invitation
NCT06859099Phase 32 sites

Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

Enrolling By Invitation
NCT07645885Not Applicable1 site

Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausal Vegan Women

Not Yet Recruiting
NCT06170788Phase 34 sites

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Recruiting
NCT06641089Phase 34 sites

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Recruiting

Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

Active Not Recruiting
NCT06158841Phase 34 sites

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting
NCT04976322Phase 31 site

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Enrolling By Invitation
NCT06422143Phase 34 sites

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Recruiting